GlassScriptPhysician profile
Jason A Davis
NPI 1053600940
$171,808.91
in general payments reported to CMS, 2019-2025
19 companies · $1,783 in 2025
The $1,783 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,971 · 2020: $5,085 · 2021: $84K · 2022: $37K · 2023: $29K · 2024: $4,591 · 2025: $1,783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $28K · Food and Beverage: $3,420 · Travel and Lodging: $2,690 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $27,949.76 |
| Food and Beverage | $3,419.64 |
| Travel and Lodging | $2,689.87 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Central California Surgical Distributors, LLC | $149,263.02 | 2020-2023 | |
| Synthes Gmbh | $14,863.13 | 2019-2024 | |
| Smith+Nephew, INC. | $2,948.46 | 2019-2025 | Evos, Trigen Intertan, Trigen |
| Stryker Corporation | $2,896.13 | 2019-2025 | Gamma, Pro, Variax |
| Depuy Synthes Sales INC. | $1,031.18 | 2019-2025 | Na, Tfn-Advance, Lcp |
| Globus Medical, INC. | $399.16 | 2022-2025 | Evo Retrograde, Troch Nail, Proximal Tibia Plate |
| Saxum Surgical, INC. | $93.92 | 2024 | |
| Baxter Healthcare | $58.36 | 2023 | Tisseel |
| My01 INC. | $55.67 | 2024-2025 | My01 Continuous Compartmental Pressure Monitor |
| Acera Surgical, INC. | $28.07 | 2025 | Restrata Wound Matrix |
| Medical Device Business Services, INC. | $27.59 | 2024 | Na |
| Pacira Pharmaceuticals Incorporated | $23.32 | 2020 | |
| Solventum Corporation | $22.73 | 2025 | Prevena |
| Ethicon US, LLC | $20.70 | 2022 | |
| Integra Lifesciences Corporation | $19.40 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $16.50 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $15.19 | 2022 | |
| Zimmer Biomet Holdings, INC. | $13.64 | 2023 | Affixus |
| Abbvie INC. | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$40,238.57 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.